• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
UBI
Click for more information
0.00% 15.0¢

UNIVERSAL BIOSENSORS INC. - Charts / Financials

Market Cap $44.71M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Medical Devices

Universal Biosensors, Inc. is a biosensor company. The Company is engaged in developing... Universal Biosensors, Inc. is a biosensor company. The Company is engaged in developing and commercializing a range of biosensors in oenology (wine industry), human health including oncology, coagulation, women’s health and fertility, non-human and environmental testing using its platform technology and hand-held point-of-use devices. Its core technology consists of a disposable, multi-layer test strip, which incorporates an electrochemical sensing system using opposing electrodes that detect specific analytes in samples as small as a droplet. Its products include Sentia Wine Analyzer, Xprecia Prime Coagulation Analyzer, Hemostasis Reference Laboratory (HRL) and PETRACKR Veterinary Blood Glucose Monitoring System. HRL supports contract research organizations, central laboratories, early phase clinics, pharmaceutical/ biotechnology companies and academic researchers conducting clinical trials. HRL offers multiplex cytokine analysis on the MESO QuickPlex SQ 120MM technology platform.More

refresh Created with Sketch. REFRESH
Last update - 10.10am 02/10/2024 (20 minute delay) ?
Day
Open 15.0¢   Day High 15.0¢   Day Low 15.0¢
Daily Volume 3419
Bids   Sellers
Number Price Volume   Number Price Volume
1 15.0¢ 3247   3 15.5¢ 10078

Directors & Senior Management

Mr. John Sharman Chief Executive Officer
Mr. Salesh Balak Chief Financial Officer, Company Secretary
Mr. Graham A. Mclean Independent Non-Executive Chairman of the Board
Mr. Craig Evan Coleman Non-Executive Director
Mr. David Leslie Hoey Non-Executive Independent Director
Ms. Judith Ann Smith Non-Executive Independent Director

Data source: Refinitiv

(20min delay)
Last
15.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $44.71M
Open High Low Value Volume
15.0¢ 15.0¢ 15.0¢ $513 3.419K

Buyers (Bids)

No. Vol. Price($)
1 3247 15.0¢
 

Sellers (Offers)

Price($) Vol. No.
15.5¢ 10078 3
View Market Depth
Last trade - 10.10am 02/10/2024 (20 minute delay) ?

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one Cobalt Blue has released estimates for what it would take to get its proposed Kwinana refinery off the ground, seeing CapEx of $60M.
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Maximus jumps 7% as it unveils latest gold drill hits at Eagles Nest; grades up to 15g/t Maximus Resources (ASX:MXR) has unveiled its latest drilling assay results at Eagles Nest, hitting gold downhole multiple assets.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.